Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23


Clinicopathological significance and prognostic role of tumor-infiltrating lymphocytes in colorectal cancer.

Ko YS, Pyo JS.

Int J Biol Markers. 2019 Mar 11:1724600818817320. doi: 10.1177/1724600818817320. [Epub ahead of print]


Delayed Trochlear Nerve Palsy Following Traumatic Subarachnoid Hemorrhage: Usefulness of High-Resolution Three Dimensional Magnetic Resonance Imaging and Unusual Course of the Nerve.

Ko YS, Yang HJ, Son YJ, Park SB, Lee SH, Chung YS.

Korean J Neurotrauma. 2018 Oct;14(2):129-133. doi: 10.13004/kjnt.2018.14.2.129. Epub 2018 Oct 31.


Extensive Pituitary Apoplexy after Chemotherapy in a Patient with Metastatic Breast Cancer.

Jang JH, Ko YS, Hong EK, Gwak HS.

Brain Tumor Res Treat. 2018 Apr;6(1):43-46. doi: 10.14791/btrt.2018.6.e7.


Clinicopathological significance and prognostic role of microvessel density in gastric cancer: A meta-analysis.

Hong WG, Ko YS, Pyo JS.

Pathol Res Pract. 2017 Dec;213(12):1459-1463. doi: 10.1016/j.prp.2017.11.001. Epub 2017 Nov 8.


FOXO1 reduces tumorsphere formation capacity and has crosstalk with LGR5 signaling in gastric cancer cells.

Choi Y, Park J, Ko YS, Kim Y, Pyo JS, Jang BG, Kim MA, Lee JS, Chang MS, Lee BL.

Biochem Biophys Res Commun. 2017 Nov 25;493(3):1349-1355. doi: 10.1016/j.bbrc.2017.09.163. Epub 2017 Sep 29.


Fascaplysin Exerts Anti-Cancer Effects through the Downregulation of Survivin and HIF-1α and Inhibition of VEGFR2 and TRKA.

Oh TI, Lee YM, Nam TJ, Ko YS, Mah S, Kim J, Kim Y, Reddy RH, Kim YJ, Hong S, Lim JH.

Int J Mol Sci. 2017 Sep 29;18(10). pii: E2074. doi: 10.3390/ijms18102074.


Concordance analysis between HER2 immunohistochemistry and in situ hybridization in non-small cell lung cancer.

Ko YS, Kim NY, Pyo JS.

Int J Biol Markers. 2018 Jan;33(1):49-54. doi: 10.5301/ijbm.5000271. Review.


FOXO1 Suppression is a Determinant of Acquired Lapatinib-Resistance in HER2-Positive Gastric Cancer Cells Through MET Upregulation.

Park J, Choi Y, Ko YS, Kim Y, Pyo JS, Jang BG, Kim MA, Lee JS, Chang MS, Park JW, Lee BL.

Cancer Res Treat. 2018 Jan;50(1):239-254. doi: 10.4143/crt.2016.580. Epub 2017 Mar 24.


HER2-induced metastasis is mediated by AKT/JNK/EMT signaling pathway in gastric cancer.

Choi Y, Ko YS, Park J, Choi Y, Kim Y, Pyo JS, Jang BG, Hwang DH, Kim WH, Lee BL.

World J Gastroenterol. 2016 Nov 7;22(41):9141-9153.


Hypoxic inactivation of glycogen synthase kinase-3β promotes gastric tumor growth and angiogenesis by facilitating hypoxia-inducible factor-1 signaling.

Ko YS, Cho SJ, Park J, Choi Y, Lee JS, Youn HD, Kim WH, Kim MA, Park JW, Lee BL.

APMIS. 2016 Sep;124(9):748-56. doi: 10.1111/apm.12569. Epub 2016 Jul 1.


c-Jun N-terminal kinase activation has a prognostic implication and is negatively associated with FOXO1 activation in gastric cancer.

Choi Y, Park J, Choi Y, Ko YS, Yu DA, Kim Y, Pyo JS, Jang BG, Kim MA, Kim WH, Lee BL.

BMC Gastroenterol. 2016 Jun 6;16(1):59. doi: 10.1186/s12876-016-0473-9.


Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression.

Ko YS, Cho SJ, Park J, Kim Y, Choi YJ, Pyo JS, Jang BG, Park JW, Kim WH, Lee BL.

Br J Cancer. 2015 Oct 20;113(8):1186-96. doi: 10.1038/bjc.2015.273. Epub 2015 Oct 8.


Signal transducers and activators of transcription 3-induced metastatic potential in gastric cancer cells is enhanced by glycogen synthase kinase-3β.

Yoon J, Ko YS, Cho SJ, Park J, Choi YS, Choi Y, Pyo JS, Ye SK, Youn HD, Lee JS, Chang MS, Kim MA, Lee BL.

APMIS. 2015 May;123(5):373-82. doi: 10.1111/apm.12370. Epub 2015 Apr 4.


Forkhead Transcription Factor FOXO1 Inhibits Angiogenesis in Gastric Cancer in Relation to SIRT1.

Kim SY, Ko YS, Park J, Choi Y, Park JW, Kim Y, Pyo JS, Yoo YB, Lee JS, Lee BL.

Cancer Res Treat. 2016 Jan;48(1):345-54. doi: 10.4143/crt.2014.247. Epub 2015 Mar 3.


Bile acid induces MUC2 expression and inhibits tumor invasion in gastric carcinomas.

Pyo JS, Ko YS, Kang G, Kim DH, Kim WH, Lee BL, Sohn JH.

J Cancer Res Clin Oncol. 2015 Jul;141(7):1181-8. doi: 10.1007/s00432-014-1890-1. Epub 2014 Dec 5.


Forkhead transcription factor FOXO1 inhibits nuclear factor-κB in gastric cancer.

Yu DA, Yoon J, Ko YS, Park J, Kim SY, Kim MA, Kim JH, Jung J, Cheon Y, Lee HS, Kim WH, Lee BL.

APMIS. 2014 Sep;122(9):848-55. doi: 10.1111/apm.12247. Epub 2014 Mar 28.


The forkhead transcription factor FOXO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase/Akt pathway.

Park J, Ko YS, Yoon J, Kim MA, Park JW, Kim WH, Choi Y, Kim JH, Cheon Y, Lee BL.

Gastric Cancer. 2014;17(3):423-30. doi: 10.1007/s10120-013-0314-2. Epub 2013 Nov 8.


A synergistic interaction between transcription factors nuclear factor-κB and signal transducers and activators of transcription 3 promotes gastric cancer cell migration and invasion.

Yoon J, Cho SJ, Ko YS, Park J, Shin DH, Hwang IC, Han SY, Nam SY, Kim MA, Chang MS, Lee HS, Kim WH, Lee BL.

BMC Gastroenterol. 2013 Feb 12;13:29. doi: 10.1186/1471-230X-13-29.


Constitutive phosphorylation of the FOXO1 transcription factor in gastric cancer cells correlates with microvessel area and the expressions of angiogenesis-related molecules.

Kim SY, Yoon J, Ko YS, Chang MS, Park JW, Lee HE, Kim MA, Kim JH, Kim WH, Lee BL.

BMC Cancer. 2011 Jun 22;11:264. doi: 10.1186/1471-2407-11-264.


Glycogen synthase kinase-3β does not correlate with the expression and activity of β-catenin in gastric cancer.

Cho YJ, Yoon J, Ko YS, Kim SY, Cho SJ, Kim WH, Park JW, Youn HD, Kim JH, Lee BL.

APMIS. 2010 Oct;118(10):782-90. doi: 10.1111/j.1600-0463.2010.02659.x.


Supplemental Content

Loading ...
Support Center